Broncus Holding Corp 02216
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$0.67
- Day Range
- HK$0.65–0.67
- 52-Week Range
- HK$0.53–3.37
- Bid/Ask
- HK$0.65 / HK$0.67
- Shares Outstanding
- 527.08M
- Market Cap
- HK$342.60M
- Volume/Avg
- 185,500 / 533,115
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 12.21
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 7.14%
Company Profile
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 195
- Website
- https://www.broncus.com
Valuation
|
Metric
|
02216
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.31 |
Price/Sales | 12.21 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
02216
|
|---|---|
Quick Ratio | 7.67 |
Current Ratio | 15.43 |
Interest Coverage | −22,760.00 |
Quick Ratio
02216
Profitability
|
Metric
|
02216
|
|---|---|
Return on Assets (Normalized) | −11.39% |
Return on Equity (Normalized) | −12.42% |
Return on Invested Capital (Normalized) | −14.87% |
Return on Assets
02216
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>y%ym@# | LOCK|cd>nw | $172B | |||
| Medtronic PLC
MDT
| LOCK|?%gpm@ | LOCK|LSQQ$ | $113B | |||
| Stryker Corp
SYK
| LOCK|%v%w^!f | LOCK|WB | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|!<yrH& | LOCK|cJ#<< | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|v%B%&&@T | LOCK|JC!# | $49B | |||
| DexCom Inc
DXCM
| LOCK|p^q><BXG | LOCK|C>X$ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|pp<HZPf | LOCK|rS^ | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%m | LOCK|?B | $24B | |||
| Steris PLC
STE
| LOCK|!Rc>wd# | LOCK|hbbjm | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|NGfPlG%! | LOCK|&XN | $17B |
United States